These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 1744586

  • 1. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, Sullivan JL.
    J Exp Med; 1991 Dec 01; 174(6):1593-600. PubMed ID: 1744586
    [Abstract] [Full Text] [Related]

  • 2. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM, Lowdell MW, Chargelegue D, Colvin BT.
    AIDS Res Hum Retroviruses; 1992 Aug 01; 8(8):1361-8. PubMed ID: 1281655
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A, Jin X, Sissons P, Borysiewicz L.
    J Exp Med; 1993 Feb 01; 177(2):249-56. PubMed ID: 8093890
    [Abstract] [Full Text] [Related]

  • 4. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ, Vyakarnam A, Cheingsong-Popov R, Callow D, Jones KL, Senior JM, Adams SE, Kingsman AJ, Matear P, Gotch FM.
    AIDS; 1993 Oct 01; 7(10):1315-23. PubMed ID: 8267904
    [Abstract] [Full Text] [Related]

  • 5. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
    Goulder PJ, Brander C, Annamalai K, Mngqundaniso N, Govender U, Tang Y, He S, Hartman KE, O'Callaghan CA, Ogg GS, Altfeld MA, Rosenberg ES, Cao H, Kalams SA, Hammond M, Bunce M, Pelton SI, Burchett SA, McIntosh K, Coovadia HM, Walker BD.
    J Virol; 2000 Jun 01; 74(12):5679-90. PubMed ID: 10823876
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Dorrell L, Willcox BE, Jones EY, Gillespie G, Njai H, Sabally S, Jaye A, DeGleria K, Rostron T, Lepin E, McMichael A, Whittle H, Rowland-Jones S.
    Eur J Immunol; 2001 Jun 01; 31(6):1747-56. PubMed ID: 11385619
    [Abstract] [Full Text] [Related]

  • 7. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
    Luzuriaga K, Koup RA, Pikora CA, Brettler DB, Sullivan JL.
    J Pediatr; 1991 Aug 01; 119(2):230-6. PubMed ID: 1907319
    [Abstract] [Full Text] [Related]

  • 8. Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals.
    Klein MR, Veenstra J, Holwerda AM, Roos MT, Gow I, Patou G, Coutinho RA, De Wolf F, Miedema F.
    AIDS Res Hum Retroviruses; 1997 Mar 20; 13(5):393-9. PubMed ID: 9075480
    [Abstract] [Full Text] [Related]

  • 9. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Mar 20; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.
    Johnson RP, Trocha A, Yang L, Mazzara GP, Panicali DL, Buchanan TM, Walker BD.
    J Immunol; 1991 Sep 01; 147(5):1512-21. PubMed ID: 1715361
    [Abstract] [Full Text] [Related]

  • 11. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S, Kaleebu P, Krausa P, Goulder P, French N, Collin B, Blanchard T, Whitworth J, McMichael A, Gotch F.
    AIDS; 1998 Apr 16; 12(6):571-9. PubMed ID: 9583596
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001 Apr 16; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
    Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Köppe B, Rosenberg W, Boyd D, Edwards A.
    Nature; 1994 Jun 02; 369(6479):403-7. PubMed ID: 7515165
    [Abstract] [Full Text] [Related]

  • 14. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.
    Buseyne F, McChesney M, Porrot F, Kovarik S, Guy B, Rivière Y.
    J Virol; 1993 Feb 02; 67(2):694-702. PubMed ID: 7678303
    [Abstract] [Full Text] [Related]

  • 15. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM, HIVNET 028 Study Team.
    J Immunol; 2004 Oct 01; 173(7):4607-17. PubMed ID: 15383595
    [Abstract] [Full Text] [Related]

  • 16. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
    Chargelegue D, O'Toole CM, Colvin BT.
    Clin Exp Immunol; 1993 Sep 01; 93(3):331-6. PubMed ID: 8370162
    [Abstract] [Full Text] [Related]

  • 17. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
    Connick E, Schlichtemeier RL, Purner MB, Schneider KM, Anderson DM, MaWhinney S, Campbell TB, Kuritzkes DR, Douglas JM, Judson FN, Schooley RT.
    J Infect Dis; 2001 Dec 01; 184(11):1465-9. PubMed ID: 11709791
    [Abstract] [Full Text] [Related]

  • 18. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D, Stanley CM, O'Toole CM, Colvin BT, Steward MW.
    Clin Exp Immunol; 1995 Feb 01; 99(2):175-81. PubMed ID: 7851008
    [Abstract] [Full Text] [Related]

  • 19. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
    Ferrari G, King K, Rathbun K, Place CA, Packard MV, Bartlett JA, Bolognesi DP, Weinhold KJ.
    Clin Exp Immunol; 1995 Aug 01; 101(2):239-48. PubMed ID: 7544247
    [Abstract] [Full Text] [Related]

  • 20. Association between HIV Type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China.
    Wang S, Zhuang Y, Zhai S, Zhao S, Kang W, Li X, Yu XG, Walker BD, Altfeld MA, Sun Y.
    AIDS Res Hum Retroviruses; 2006 Aug 01; 22(8):780-7. PubMed ID: 16910834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.